Siravyadana or bloodletting in heel pain

Efficacy of Siravyadana in plantar fasciitis: a randomized, open-labeled, controlled trial - Nil

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/09/094088

Enrollment

Registered

2025-09-02

Start date

Unknown

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M722- Plantar fascial fibromatosis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Subjects with inferior heel Pain

Exclusion criteria

Exclusion criteria: 1. Chronic pain syndrome or lumbosacral radiculitis 2. Neurological conditions such as peripheral neuropathy, polyneuropathy & radiculopathy 3. Peripheral vascular disease that results in rest pain or intermittent claudication 4. Patients with foot and arch issues such as flat foot and high arch foot 5. Calcaneal stress fracture 6. Spondyloarthropathies, Rheumatoid arthritis 7. Osteomyelitis of calcaneum 8. Patients unfit for the procedure of Siravyadana

Design outcomes

Primary

Measure	Time frame
Change in Foot Function Index (FFI)Timepoint: Baseline, week 2, week 4, week 6, week 8, week 10 & week 12	—

Secondary

Measure	Time frame
Change in thickness in plantar fascia assessed by high-resolution ultrasonographyTimepoint: Baseline & week 12;Satisfaction with the result of the treatmentTimepoint: week 12;Change in hs-CRPTimepoint: Baseline & week 12	—

Countries

India

Contacts

Public ContactPratap Shankar K M

National Ayurveda Research Institute for Panchakarma

kmpvarma@gmail.com9744824014

Outcome results